A Study of Insulin Peglispro in Healthy Male Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2928057 in Hemodialysis Participants
- Status
- COMPLETED
- Phase
- PHASE1
GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2801653 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
- Status
- COMPLETED
- Phase
- PHASE3
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets
- Status
- COMPLETED
- Phase
- PHASE1
Inpatient Diabetes on Corticosteroids
- Status
- COMPLETED
- Phase
- PHASE4
Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
- Status
- COMPLETED
- Phase
- PHASE2
Exenatide for Stress Hyperglycemia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of LY3127760 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Baricitinib and Ciclosporin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2157299 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of [14C]-LY3023703 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Baricitinib and Simvastatin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Immunogenicity of a Novel Glucagon Formulation
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Evacetrapib in Japanese and Non-Japanese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of Mirikizumab (LY3074828)
- Status
- COMPLETED
- Phase
- PHASE1